Exact Mass: 455.198239624
Exact Mass Matches: 455.198239624
Found 500 metabolites which its exact mass value is equals to given mass value 455.198239624,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
20-Hydroxy-leukotriene E4
C23H37NO6S (455.23414620000005)
20-Hydroxy-leukotriene E4 is a metabolite that can originate from the lipid oxidation of leukotriene E4 (LTE4). LTE4 is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4 activates contractile and inflammatory processes via specific interactions with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent and are able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signaling pathways.
Lacidipine
C26H33NO6 (455.23077580000006)
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Methylergonovine maleate
C24H29N3O6 (455.20562540000003)
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D012102 - Reproductive Control Agents > D010120 - Oxytocics
2-Hydroxy-2-[2-[[4-[[3-[(3,4-dihydroxybenzoyl)amino]propyl]amino]butyl]amino]-2-oxoethyl]-butanedioic acid
5,10-Methenyltetrahydrofolic acid
C20H21N7O6 (455.15532460000003)
Folate is important for cells and tissues that rapidly divide. Cancer cells divide rapidly, and drugs that interfere with folate metabolism are used to treat cancer. Methotrexate is a drug often used to treat cancer because it inhibits the production of the active form, tetrahydrofolate. Unfortunately, methotrexate can be toxic, producing side effects such as inflammation in the digestive tract that make it difficult to eat normally. Folinic acid is a form of folate that can help rescue or reverse the toxic effects of methotrexate. Folinic acid is not the same as folic acid. Folic acid supplements have little established role in cancer chemotherapy. There have been cases of severe adverse effects of accidental substitution of folic acid for folinic acid in patients receiving methotrexate cancer chemotherapy. It is important for anyone receiving methotrexate to follow medical advice on the use of folic or folinic acid supplements. Low concentrations of folate, vitamin B12, or vitamin B6 may increase your level of homocysteine, an amino acid normally found in your blood. There is evidence that an elevated homocysteine level is an independent risk factor for heart disease and stroke. The evidence suggests that high levels of homocysteine may damage coronary arteries or make it easier for blood clotting cells called platelets to clump together and form a clot. However, there is currently no evidence available to suggest that lowering homocysteine with vitamins will reduce your risk of heart disease. Clinical intervention trials are needed to determine whether supplementation with folic acid, vitamin B12 or vitamin B6 can lower your risk of developing coronary heart disease. Methylene tetrahydrofolate (CH2FH4) is formed from tetrahydrofolate by the addition of methylene groups from one of three carbon donors: formaldehyde, serine, or glycine. Methyl tetrahydrofolate(CH3FH4) can be made from methylene tetrahydrofolate by reduction of the methylene group, and formyl tetrahydrofolate (CHOFH4, folinic acid) is made by oxidation of methylene tetrahydrofolate. In the form of a series of tetrahydrofolate compounds, folate derivatives are substrates in a number of single-carbon-transfer reactions, and also are involved in the synthesis of dTMP (2-deoxythymidine-5-phosphate) from dUMP (2-deoxyuridine-5-phosphate). It helps convert vitamin B12 to one of its coenzyme forms and helps synthesize the DNA required for all rapidly growing cells.
Erythroskyrin
C26H33NO6 (455.23077580000006)
Erythroskyrin is a mycotoxin produced by the common food storage mould Penicillium islandicu
Tryptophol [xylosyl-(1->6)-glucoside]
C21H29NO10 (455.17913740000006)
Tryptophol [xylosyl-(1->6)-glucoside] is found in coffee and coffee products. Tryptophol [xylosyl-(1->6)-glucoside] is isolated from Lycium chinense (Chinese boxthom). Isolated from Lycium chinense (Chinese boxthom). Tryptophol [xylosyl-(1->6)-glucoside] is found in tea, coffee and coffee products, and herbs and spices.
(4S)-4-[[4-(3-Amino-1-oxo-5,6,6a,7-tetrahydro-2H-imidazo[1,5-f]pteridin-10-ium-8-yl)benzoyl]amino]-5-hydroxy-5-oxopentanoate
C20H21N7O6 (455.15532460000003)
Aminoquinol
N-(6-Amino-2-methyl-pyridin-3-ylmethyl)-2-(6-methyl-2-oxo-3-phenylmethanesulfonylamino-2H-pyridin-1-yl)-acetamide
C22H25N5O4S (455.16271700000004)
Lacidipine
C26H33NO6 (455.23077580000006)
N-Pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide
Redafamdastat (PF-04457845) is a highly efficacious and selective FAAH inhibitor with IC50 values is 7.2±0.63 nM and 7.4±0.62 nM for hFAAH and rFAAH, respectively.
Pradigastat
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent Pradigastat (LCQ-908) is a potent, selective and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor. Pradigastat has anti-obesity and anti-diabetic effects[1][2].
2-[[4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-5-methoxy-5-oxopentanoic acid
C20H21N7O6 (455.15532460000003)
2-[[4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-4-methylpentanedioic acid
C20H21N7O6 (455.15532460000003)
2,6-dimethyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester
C26H33NO6 (455.23077580000006)
Lipoxin E4
C23H37NO6S (455.23414620000005)
3alpha-(3,4,5-trimethoxycinnamoyloxy)tropan-6beta-benzoyloxytropane
3-[11-(3-Hydroxy-5-methyl-hexahydro-furo[3,2-b]furan-2-yl)-undeca-2,4,6,8,10-pentaenoyl]-5-isopropyl-1-methyl-pyrrolidin-2,4-dion|3-[11-(3-hydroxy-5-methyl-hexahydro-furo[3,2-b]furan-2-yl)-undeca-2,4,6,8,10-pentaenoyl]-5-isopropyl-1-methyl-pyrrolidine-2,4-dione
C26H33NO6 (455.23077580000006)
Ala Asn His Asp
Ala Asp His Asn
Ala Asp Asn His
Ala His Asp Asn
Ala His Asn Asp
Ala His Gln Thr
Ala His Thr Gln
Ala Asn Asp His
Ala Gln His Thr
Ala Gln Thr His
Ala Thr His Gln
Ala Thr Gln His
Asp Ala His Asn
Asp Ala Asn His
Asp Gly His Lys
Asp Gly His Gln
Asp Gly Lys His
Asp Gly Gln His
Asp His Ala Asn
Asp His Gly Lys
Asp His Gly Gln
Asp His Lys Gly
Asp His Asn Ala
Asp His Gln Gly
Asp Lys Gly His
Asp Lys His Gly
Asp Lys Pro Pro
C20H33N5O7 (455.23798680000004)
Asp Asn Ala His
Asp Asn His Ala
Asp Pro Lys Pro
C20H33N5O7 (455.23798680000004)
Asp Pro Pro Lys
C20H33N5O7 (455.23798680000004)
Asp Pro Pro Gln
Asp Pro Gln Pro
Asp Gln Gly His
Asp Gln His Gly
Asp Gln Pro Pro
Glu Gly His Asn
Glu Gly Asn His
Glu His Gly Asn
Glu His Asn Gly
Glu Asn Gly His
Glu Asn His Gly
Glu Asn Pro Pro
Glu Pro Asn Pro
Glu Pro Pro Asn
Gly Asp His Lys
Gly Asp His Gln
Gly Asp Lys His
Gly Asp Gln His
Gly Glu His Asn
Gly Glu Asn His
Gly Gly His Trp
Gly Gly Trp His
Gly His Asp Lys
Gly His Asp Gln
Gly His Glu Asn
Gly His Gly Trp
Gly His Lys Asp
Gly His Asn Glu
Gly His Gln Asp
Gly His Arg Ser
Gly His Ser Arg
Gly His Trp Gly
Gly Lys Asp His
Gly Lys His Asp
Gly Asn Glu His
Gly Asn His Glu
Gly Pro Pro Trp
C23H29N5O5 (455.21685840000004)
Gly Pro Trp Pro
C23H29N5O5 (455.21685840000004)
Gly Gln Asp His
Gly Gln His Asp
Gly Arg His Ser
Gly Arg Ser His
Gly Ser His Arg
Gly Ser Arg His
Gly Trp Gly His
Gly Trp His Gly
Gly Trp Pro Pro
C23H29N5O5 (455.21685840000004)
His Ala Asp Asn
His Ala Asn Asp
His Ala Gln Thr
His Ala Thr Gln
His Asp Ala Asn
His Asp Gly Lys
His Asp Gly Gln
His Asp Lys Gly
His Asp Asn Ala
His Asp Gln Gly
His Glu Gly Asn
His Glu Asn Gly
His Gly Asp Lys
His Gly Asp Gln
His Gly Glu Asn
His Gly Gly Trp
His Gly Lys Asp
His Gly Asn Glu
His Gly Gln Asp
His Gly Arg Ser
His Gly Ser Arg
His Gly Trp Gly
His Lys Asp Gly
His Lys Gly Asp
His Asn Ala Asp
His Asn Asp Ala
His Asn Glu Gly
His Asn Gly Glu
His Asn Ser Val
His Asn Val Ser
His Gln Ala Thr
His Gln Asp Gly
His Gln Gly Asp
His Gln Thr Ala
His Arg Gly Ser
His Arg Ser Gly
His Ser Gly Arg
His Ser Asn Val
His Ser Arg Gly
His Ser Val Asn
His Thr Ala Gln
His Thr Gln Ala
His Val Asn Ser
His Val Ser Asn
His Trp Gly Gly
Lys Asp Gly His
Lys Asp His Gly
Lys Asp Pro Pro
C20H33N5O7 (455.23798680000004)
Lys Gly Asp His
Lys Gly His Asp
Lys His Asp Gly
Lys His Gly Asp
Lys Pro Asp Pro
C20H33N5O7 (455.23798680000004)
Lys Pro Pro Asp
C20H33N5O7 (455.23798680000004)
Asn Ala Asp His
Asn Ala His Asp
Asn Asp Ala His
Asn Asp His Ala
Asn Glu Gly His
Asn Glu His Gly
Asn Glu Pro Pro
Asn Gly Glu His
Asn Gly His Glu
Asn His Ala Asp
Asn His Asp Ala
Asn His Glu Gly
Asn His Gly Glu
Asn His Ser Val
Asn His Val Ser
Asn Pro Glu Pro
Asn Pro Pro Glu
Asn Ser His Val
Asn Ser Val His
Asn Val His Ser
Asn Val Ser His
Pro Asp Lys Pro
C20H33N5O7 (455.23798680000004)
Pro Asp Pro Lys
C20H33N5O7 (455.23798680000004)
Pro Asp Pro Gln
Pro Asp Gln Pro
Pro Glu Asn Pro
Pro Glu Pro Asn
Pro Gly Pro Trp
C23H29N5O5 (455.21685840000004)
Pro Gly Trp Pro
C23H29N5O5 (455.21685840000004)
Pro Lys Asp Pro
C20H33N5O7 (455.23798680000004)
Pro Lys Pro Asp
C20H33N5O7 (455.23798680000004)
Pro Asn Glu Pro
Pro Asn Pro Glu
Pro Pro Asp Lys
C20H33N5O7 (455.23798680000004)
Pro Pro Asp Gln
Pro Pro Glu Asn
Pro Pro Gly Trp
C23H29N5O5 (455.21685840000004)
Pro Pro Lys Asp
C20H33N5O7 (455.23798680000004)
Pro Pro Asn Glu
Pro Pro Gln Asp
Pro Pro Trp Gly
C23H29N5O5 (455.21685840000004)
Pro Gln Asp Pro
Pro Gln Pro Asp
Pro Trp Gly Pro
C23H29N5O5 (455.21685840000004)
Pro Trp Pro Gly
C23H29N5O5 (455.21685840000004)
Gln Ala His Thr
Gln Ala Thr His
Gln Asp Gly His
Gln Asp His Gly
Gln Asp Pro Pro
Gln Gly Asp His
Gln Gly His Asp
Gln His Ala Thr
Gln His Asp Gly
Gln His Gly Asp
Gln His Thr Ala
Gln Pro Asp Pro
Gln Pro Pro Asp
Gln Thr Ala His
Gln Thr His Ala
Arg Gly His Ser
Arg Gly Ser His
Arg His Gly Ser
Arg His Ser Gly
Arg Ser Gly His
Arg Ser His Gly
Ser Gly His Arg
Ser Gly Arg His
Ser His Gly Arg
Ser His Asn Val
Ser His Arg Gly
Ser His Val Asn
Ser Asn His Val
Ser Asn Val His
Ser Arg Gly His
Ser Arg His Gly
Ser Val His Asn
Ser Val Asn His
Thr Ala His Gln
Thr Ala Gln His
Thr His Ala Gln
Thr His Gln Ala
Thr Gln Ala His
Thr Gln His Ala
Val His Asn Ser
Val His Ser Asn
Val Asn His Ser
Val Asn Ser His
Val Ser His Asn
Val Ser Asn His
Trp Gly Gly His
Trp Gly His Gly
Trp Gly Pro Pro
C23H29N5O5 (455.21685840000004)
Trp His Gly Gly
Trp Pro Gly Pro
C23H29N5O5 (455.21685840000004)
Trp Pro Pro Gly
C23H29N5O5 (455.21685840000004)
Indomethacin heptyl ester
C26H30ClNO4 (455.18632500000007)
Erythroskyrin
C26H33NO6 (455.23077580000006)
Tryptophol [xylosyl-(1->6)-glucoside]
C21H29NO10 (455.17913740000006)
20-hydroxy-LTE4
C23H37NO6S (455.23414620000005)
20-Hydroxy-leukotriene E4
C23H37NO6S (455.23414620000005)
16-carboxy-Delta(13)-17,18,19,20-tetranor-N-acetyl-leukotriene E4
C21H29NO8S (455.16137940000004)
N-(1-Phenyl-5-[(piperidin-1-yl)methyl]-1H-benzimidazol-2-yl)-3-nitrobenzamide
2-(5-METHYL-2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)PYRIMIDIN-4-YL)BENZO[B]THIOPHENE-5-CARBONITRILE
dimethyl (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
Lisdexamfetamine dimesylate
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant C78272 - Agent Affecting Nervous System > C29728 - Anorexiant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators
1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]-1-propanone
C29H26ClNO2 (455.16519660000006)
13H-spiro[benzo[c]indeno[2,1-a]carbazole-14,9-fluorene]
4-[3-[4,7-dimethoxy-6-(2-piperidin-1-ylethoxy)-1-benzofuran-5-yl]-3-hydroxypropyl]phenol
C26H33NO6 (455.23077580000006)
Aminoquinol
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
(2R,3R)-N^1^-[(1S)-2,2-Dimethyl-1-(methylcarbamoyl)propyl]-N^4^-hydroxy-2-(2-methylpropyl)-3-{[(1,3-thiazol-2-ylcarbonyl)amino]methyl}butanediamide
C20H33N5O5S (455.2202288000001)
Moxifloxacin hydrochloride monohydrate
C21H27ClFN3O5 (455.16231740000006)
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones D004791 - Enzyme Inhibitors
Ibuprofen aluminum
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor
Ro 25-6981 maleate
C26H33NO6 (455.23077580000006)
Ro 25-6981 Maleate is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 Maleat shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 Maleate has the potential for the research of parkinson's disease (PD)[1][2][3].
Platensimycin Methyl Ester
A polycyclic cage compound that is methyl ester derivative of platensimycin. It is isolated from Streptomyces platensis.
Platencin A3 Methyl Ester
A polycyclic cage that is the methyl ester derivative of platencin A3. It is isolated from Streptomyces platensis.
Platencin A2 Methyl Ester
A polycyclic cage that is the methyl ester derivative of platencin A2. It is isolated from Streptomyces platensis.
Platencin A1 Methyl Ester
A polycyclic cage that is the methyl ester derivative of platencin A1. It is isolated from Streptomyces platensis.
Allyl-{6-[3-(4-bromo-phenyl)-1-methyl-1H-indazol-6-YL]oxy}hexyl)-N-methylamine
3-(2-Chlorophenyl)-1-(2-{[(1S)-2-hydroxy-1,2-dimethylpropyl]amino}pyrimidin-4-YL)-1-(4-methoxyphenyl)urea
C23H26ClN5O3 (455.17240760000004)
Morpholine-4-carboxylic acid [1-(2-benzylsulfanyl-1-formyl-ethylcarbamoyl)-2-phenyl-ethyl]-amide
C24H29N3O4S (455.1878674000001)
(1S)-2-{[{[(2S)-2,3-Dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(pentanoyloxy)methyl]ethyl octanoate
Pradigastat
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent Pradigastat (LCQ-908) is a potent, selective and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor. Pradigastat has anti-obesity and anti-diabetic effects[1][2].
2-(4-Fluorophenyl)-5-(1-benzyloxycarbonylpiperidin-4-yl)-3-(4-pyridinyl)pyrrole
1-Tetradecanoyl-sn-glycero-3-phospho-(1-sn-glycerol)(1-)
C20H40O9P- (455.2409820000001)
Latrunculol A
C22H33NO7S (455.1977628000001)
A natural product found in Cacospongia mycofijiensis.
4-(2-amino-3-cyano-5-oxo-5,6,7,8-tetrahydro-4H-chromen-4-yl)-2,6-dimethoxyphenyl morpholine-4-carboxylate
ethyl 4-[3-oxo-3-[(12-oxo-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-2-yl)amino]propanoyl]piperazine-1-carboxylate
C23H29N5O5 (455.21685840000004)
4-[4-[(1R,5S)-3-(1,3-benzodioxol-5-ylmethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
C28H29N3O3 (455.22088040000006)
(3R,6aS,8S,10aS)-3-hydroxy-8-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-N-phenyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C23H29N5O5 (455.21685840000004)
N-[(2R)-1-hydroxypropan-2-yl]-N-[(2R,3S)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
N-[(2R)-1-hydroxypropan-2-yl]-N-[(2S,3R)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
N-[(2S)-1-hydroxypropan-2-yl]-N-[(2S,3S)-3-methoxy-2-methyl-4-[methyl(1,3-thiazol-2-ylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N,N-dimethyl-4-[3-[(E)-prop-1-enyl]phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C25H33N3O3S (455.22425080000005)
(3R,6aS,8R,10aS)-3-hydroxy-8-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-N-phenyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C23H29N5O5 (455.21685840000004)
3-fluoro-N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
N-[(4S,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4S,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4S,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
2-[(2R,5S,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O6 (455.20562540000003)
2-[(2S,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O6 (455.20562540000003)
2-[(2R,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C24H29N3O6 (455.20562540000003)
2-[(2R,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C24H29N3O6 (455.20562540000003)
2-[(2S,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C24H29N3O6 (455.20562540000003)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H29N3O6 (455.20562540000003)
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H29N3O6 (455.20562540000003)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H29N3O6 (455.20562540000003)
N-[(2S)-1-hydroxypropan-2-yl]-N-[(2R,3R)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
N-[(2R)-1-hydroxypropan-2-yl]-N-[(2S,3S)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
N-[(2R)-1-hydroxypropan-2-yl]-N-[(2R,3R)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
(3S,6aR,8S,10aR)-3-hydroxy-8-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-N-phenyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C23H29N5O5 (455.21685840000004)
(2S,3S,3aR,9bR)-2-[3,4-dihydro-1H-isoquinolin-2-yl(oxo)methyl]-3-(hydroxymethyl)-1-methyl-7-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
C28H29N3O3 (455.22088040000006)
3-[4-[(8R,9S,10S)-6-[(2-fluorophenyl)methyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]benzonitrile
3-[4-[(8S,9S,10S)-6-[(2-fluorophenyl)methyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]benzonitrile
[(1R)-1-(benzenesulfonyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C24H29N3O4S (455.1878674000001)
[(1S)-7-methoxy-2,9-dimethyl-1-(3-methylphenyl)sulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C24H29N3O4S (455.1878674000001)
[(1R)-7-methoxy-2,9-dimethyl-1-(3-methylphenyl)sulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C24H29N3O4S (455.1878674000001)
3-fluoro-N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
N-[(4S,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4R,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4R,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4R,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O6S (455.2089958000001)
2-[(2S,5R,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C24H29N3O6 (455.20562540000003)
2-[(2S,5R,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O6 (455.20562540000003)
2-[(2R,5S,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C24H29N3O6 (455.20562540000003)
2-[(2S,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide
C24H29N3O6 (455.20562540000003)
2-[(2R,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O6 (455.20562540000003)
2-[(2R,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O6 (455.20562540000003)
2-[(2S,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide
C24H29N3O6 (455.20562540000003)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H29N3O6 (455.20562540000003)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H29N3O6 (455.20562540000003)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H29N3O6 (455.20562540000003)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H29N3O6 (455.20562540000003)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H29N3O6 (455.20562540000003)
N-[(2S)-1-hydroxypropan-2-yl]-N-[(2S,3R)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
N-[(2S)-1-hydroxypropan-2-yl]-N-[(2R,3S)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
(3R,6aR,8S,10aR)-3-hydroxy-8-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-N-phenyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C23H29N5O5 (455.21685840000004)
(3S,6aR,8R,10aR)-3-hydroxy-8-[2-oxo-2-(4-pyrimidinylmethylamino)ethyl]-N-phenyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C23H29N5O5 (455.21685840000004)
(1R,9S,10S,11S)-10-(hydroxymethyl)-6-oxo-5-[(E)-2-phenylethenyl]-N-[(1S)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C28H29N3O3 (455.22088040000006)
(2R,3R,3aS,9bS)-2-[3,4-dihydro-1H-isoquinolin-2-yl(oxo)methyl]-3-(hydroxymethyl)-1-methyl-7-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
C28H29N3O3 (455.22088040000006)
(2R,3R,3aS,9bS)-1-(cyclopropylmethyl)-3-(hydroxymethyl)-6-oxo-N-(4-phenylphenyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C28H29N3O3 (455.22088040000006)
3-[4-[(8S,9R,10R)-6-[(2-fluorophenyl)methyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]benzonitrile
3-[4-[(8S,9S,10R)-6-[(2-fluorophenyl)methyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]benzonitrile
3-[4-[(8R,9R,10S)-6-[(2-fluorophenyl)methyl]-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]benzonitrile
3-[4-[(1S,5R)-6-(1,3-benzodioxol-5-ylmethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
C28H29N3O3 (455.22088040000006)
[(2S)-2,3-dihydroxypropyl] [(2S)-2-hydroxy-3-tetradecanoyloxypropyl] phosphate
C20H40O9P- (455.2409820000001)
diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-3,4-dihydropyridine-3,5-dicarboxylate
C26H33NO6 (455.23077580000006)
2-[2-(3-methoxyphenyl)-2-oxoethyl]-N-[2-(3-methylphenyl)ethyl]-3-oxo-4H-quinoxaline-6-carboxamide
[(5E)-5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-(1H-pyridin-4-ylidene)-1H-imidazol-4-ylidene]-2,3-dihydroinden-1-yl]-oxidoazanium
2-Amino-3-[hydroxy-(2-hydroxy-3-tridecanoyloxypropoxy)phosphoryl]oxypropanoic acid
C19H38NO9P (455.2284068000001)
2-Amino-3-[2,3-di(hexanoyloxy)propoxy-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-butanoyloxy-2-octanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(2-nonanoyloxy-3-propanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[(2-heptanoyloxy-3-pentanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
cis-5-(6-(1,3-Dithian-2-YL)hexyl)-trans-4-formyl-2,ref.-3-diphenylisoxazolidine
C26H33NO2S2 (455.19525980000003)
3-[(3-Acetyloxy-2-decanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
1-tridecanoyl-sn-glycero-3-phosphoserine
C19H38NO9P (455.2284068000001)
AD57
C22H20F3N7O (455.16813460000003)
AD57 is an orally active multikinase inhibitor, inhibits RET, BRAF, S6K and Src, with greatly reduces mTOR activity[1].
CMF019
C25H33N3O3S (455.22425080000005)
CMF019 is a potent and small molecule agonist at Apelin receptor (APJ) with G protein bias. CMF019 binds to APJ with pKi values of 8.58, 8.49 and 8.71 for human, rat, and mouse, respectively. CMF019 mimics the beneficial cardiovascular actions of apelin in rodents[1]. Apelin receptor (APJ) is a G protein-coupled receptor (GPCR) activated by the endogenous peptide apelin[2].
Diprotin A (TFA)
Diprotin A TFA (Ile-Pro-Ile TFA) is an inhibitor of dipeptidyl peptidase IV (DPP-IV)[1].
GNE-9815
GNE-9815 (compound 7) is a highly selective, pan-RAF inhibitor with good oral bioavailability. GNE-9815 exhibits Ki values of 0.062 and 0.19 nM for CRAF and BRAF, respectively. GNE-9815 combines with MEK inhibitor Cobimetinib (HY-13064) shows synergistic modulation of MAPK pathway. GNE-9815 can be used in studies of KRAS mutant cancers[1].
(1s,6r,10r,12r,19s,20r,21s)-21-(dimethylamino)-16,20-dihydroxy-12,19-dimethyl-7,11,23-trioxahexacyclo[17.3.1.0²,¹⁸.0³,¹⁵.0⁵,¹³.0⁶,¹⁰]tricosa-2,5(13),15,17-tetraene-4,8,14-trione
(2e,4e,6r)-n-[(1r,2s,4r,6s,7s,8s,10s)-6-chloro-1,7,10-trihydroxy-5-oxo-3-oxatricyclo[4.3.1.0²,⁴]decan-8-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C23H34ClNO6 (455.2074534000001)
[(2r,3r,4r,5s,6r)-2-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-2-{[(2s)-1-hydroxy-3-oxopropan-2-yl]oxy}-6-methyloxan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]amino acetate
C17H29NO13 (455.16388240000003)
(1r,4r,5r,8r,9s,19r)-4-[(2s)-butan-2-yl]-9-ethyl-4,5,9-trihydroxy-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C22H33NO9 (455.21552080000004)
[2-({4,5-dihydroxy-2-[(1-hydroxy-3-oxopropan-2-yl)oxy]-6-methyloxan-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]amino acetate
C17H29NO13 (455.16388240000003)
2,3-bis(acetyloxy)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-10-yl acetate
C26H33NO6 (455.23077580000006)
5-amino-6-[(6-amino-2-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,4-dihydroxycyclohexyl)oxy]-2-(aminomethyl)oxane-3,4-diol
C17H33N3O11 (455.21149879999996)
(2e,4e)-n-[(3s)-7,9-dichloro-2-hydroxy-8-oxo-1-oxaspiro[4.5]deca-6,9-dien-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
(3r,5s)-3-[(2e,4e,6e,8e,10e)-11-[(2r,3r,3as,5s,6as)-3-hydroxy-5-methyl-hexahydrofuro[3,2-b]furan-2-yl]undeca-2,4,6,8,10-pentaenoyl]-5-isopropyl-1-methylpyrrolidine-2,4-dione
C26H33NO6 (455.23077580000006)
3-[({10-amino-10-benzyl-7,9,10a-trihydroxy-3-oxo-1h,2h,5h-pyrrolo[1,2-b]isoquinolin-5-yl}(hydroxy)methylidene)amino]propanoic acid
n-[2,6-dihydroxy-3-(methoxycarbonyl)phenyl]-3-[(1r,5s,8r,11r)-11-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propanimidic acid
(1's,14'r)-1'-{[(4s)-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-13'-oxa-8',11'-diazaspiro[cyclopropane-1,10'-tetracyclo[6.5.1.0²,⁷.0¹¹,¹⁴]tetradecane]-2',4',6'-trien-9'-one
C25H21N5O4 (455.15934660000005)
(3r)-3-{[(2r,3s,4s,5r)-5-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1,2,3,4,6-pentahydroxyhexylidene]amino}-3-phenylpropanoic acid
C21H33N3O8 (455.22675380000004)
21-(dimethylamino)-16,20-dihydroxy-12,19-dimethyl-7,11,23-trioxahexacyclo[17.3.1.0²,¹⁸.0³,¹⁵.0⁵,¹³.0⁶,¹⁰]tricosa-2,5(13),15,17-tetraene-4,8,14-trione
(1r,4r,5s,8r,9s,19r)-9-ethyl-4,5,9-trihydroxy-8-methyl-4-(sec-butyl)-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C22H33NO9 (455.21552080000004)
2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-(1h-indol-3-yl)ethoxy]oxane-3,4,5-triol
C21H29NO10 (455.17913740000006)
2-[(4,6-diamino-3-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl)oxy]oxane-3,4,5-triol
C17H33N3O11 (455.21149879999996)
(2r,3s,4r,5r,6r)-5-amino-6-{[(1r,2r,3s,4r,6s)-6-amino-2-{[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,4-dihydroxycyclohexyl]oxy}-2-(aminomethyl)oxane-3,4-diol
C17H33N3O11 (455.21149879999996)
n-[2,6-dihydroxy-3-(methoxycarbonyl)phenyl]-3-[(1r,5s,6s,8r,11r)-11-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propanimidic acid
3-({5-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-1,2,3,4,6-pentahydroxyhexylidene}amino)-3-phenylpropanoic acid
C21H33N3O8 (455.22675380000004)
(20s,21s)-21-hydroxy-4,5,6,10,11-pentamethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-16-ium-16-olate
(2e,4e,6r)-n-[(2s,3s)-7,9-dichloro-2-hydroxy-8-oxo-1-oxaspiro[4.5]deca-6,9-dien-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
(9s,12s,15s)-9-amino-4,10,13-trihydroxy-12-(2-methylpropyl)-2-oxa-11,14-diazatricyclo[15.2.2.1³,⁷]docosa-1(19),3(22),4,6,10,13,17,20-octaene-15-carboxylic acid
C24H29N3O6 (455.20562540000003)
4,5,9-trihydroxy-4,9-diisopropyl-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C22H33NO9 (455.21552080000004)
(2s)-3-acetyl-2-aminopentanedioic acid; bis(oxindole)
8,9,17-trihydroxy-17-(2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl)-5,12-dimethyl-2,16-dioxabicyclo[13.3.1]nonadeca-4,10-dien-3-one
C22H33NO7S (455.1977628000001)
(2e,4e)-n-{7,9-dichloro-2-hydroxy-8-oxo-1-oxaspiro[4.5]deca-6,9-dien-3-yl}-4,6-dimethyldodeca-2,4-dienimidic acid
(1r,6r,10r,12r,19r,20s,21r)-21-(dimethylamino)-16,20-dihydroxy-12,19-dimethyl-7,11,23-trioxahexacyclo[17.3.1.0²,¹⁸.0³,¹⁵.0⁵,¹³.0⁶,¹⁰]tricosa-2,5(13),15,17-tetraene-4,8,14-trione
(1r,4z,8s,9s,10z,12s,15r,17r)-8,9,17-trihydroxy-17-[(4s)-2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl]-5,12-dimethyl-2,16-dioxabicyclo[13.3.1]nonadeca-4,10-dien-3-one
C22H33NO7S (455.1977628000001)
(1r,4z,8s,9s,10z,12s,15r,17r)-8,9,17-trihydroxy-17-[(4r)-2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl]-5,12-dimethyl-2,16-dioxabicyclo[13.3.1]nonadeca-4,10-dien-3-one
C22H33NO7S (455.1977628000001)
9-ethyl-4,5,9-trihydroxy-8-methyl-4-(sec-butyl)-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
C22H33NO9 (455.21552080000004)
(16r,20s,21s)-21-hydroxy-4,5,6,10,11-pentamethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-16-ium-16-olate
methyl 4-oxo-4-[(9s)-4,5,15,16-tetramethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-10-yl]butanoate
(1r,4z,8r,9s,10z,12s,15r,17r)-8,9,17-trihydroxy-17-[(4r)-2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl]-5,12-dimethyl-2,16-dioxabicyclo[13.3.1]nonadeca-4,10-dien-3-one
C22H33NO7S (455.1977628000001)
(1s,2s,3s,5r,8r,9s,10r,11s,14r,16s,17r,18r)-2,3-bis(acetyloxy)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-10-yl acetate
C26H33NO6 (455.23077580000006)
5-hydroxy-4-[(2e,4e,6e,8e,10e)-11-{3-hydroxy-5-methyl-hexahydrofuro[3,2-b]furan-2-yl}undeca-2,4,6,8,10-pentaenoyl]-2-isopropyl-1-methyl-2h-pyrrol-3-one
C26H33NO6 (455.23077580000006)
(5s)-3-[(2e,4e,6e,8e,10e)-11-[(2s,3r,3ar,5r,6ar)-3-hydroxy-5-methyl-hexahydrofuro[3,2-b]furan-2-yl]-1-hydroxyundeca-2,4,6,8,10-pentaen-1-ylidene]-5-isopropyl-1-methylpyrrolidine-2,4-dione
C26H33NO6 (455.23077580000006)
(3s)-3-{[(2s,3r,4r,5s)-5-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1,2,3,4,6-pentahydroxyhexylidene]amino}-3-phenylpropanoic acid
C21H33N3O8 (455.22675380000004)
3-(11-{3-hydroxy-5-methyl-hexahydrofuro[3,2-b]furan-2-yl}undeca-2,4,6,8,10-pentaenoyl)-5-isopropyl-1-methylpyrrolidine-2,4-dione
C26H33NO6 (455.23077580000006)
(2r,3s,4s,5r,6r)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-(1h-indol-3-yl)ethoxy]oxane-3,4,5-triol
C21H29NO10 (455.17913740000006)
1'-({3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl}methyl)-13'-oxa-8',11'-diazaspiro[cyclopropane-1,10'-tetracyclo[6.5.1.0²,⁷.0¹¹,¹⁴]tetradecane]-2',4',6'-trien-9'-one
C25H21N5O4 (455.15934660000005)
n-{6-chloro-1,7,10-trihydroxy-5-oxo-3-oxatricyclo[4.3.1.0²,⁴]decan-8-yl}-4,6-dimethyldodeca-2,4-dienimidic acid
C23H34ClNO6 (455.2074534000001)